What is the recommended treatment for Pertussis (Whooping Cough)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pertussis (Whooping Cough)

Azithromycin is the preferred first-line treatment for pertussis in all age groups due to its better tolerability, fewer side effects, and more convenient dosing schedule compared to alternatives. 1

Recommended Antimicrobial Regimens

Azithromycin (First-line)

  • Infants <6 months: 10 mg/kg per day for 5 days 2, 1
  • Infants and children ≥6 months: 10 mg/kg (maximum: 500 mg) on day 1, followed by 5 mg/kg per day (maximum: 250 mg) on days 2-5 2, 1
  • Adults: 500 mg on day 1, followed by 250 mg per day on days 2-5 2, 1

Erythromycin (Alternative)

  • Infants <1 month: Not preferred due to risk of infantile hypertrophic pyloric stenosis (IHPS). Use azithromycin instead. If unavailable, dose is 40-50 mg/kg per day in 4 divided doses for 14 days with monitoring for IHPS 2
  • Infants ≥1 month and children: 40-50 mg/kg per day (maximum: 2 g per day) in 4 divided doses for 14 days 2, 3
  • Adults: 2 g per day in 4 divided doses for 14 days 2, 3

Clinical Evidence and Considerations

Azithromycin has demonstrated equal efficacy to erythromycin with significantly fewer side effects. In a large randomized controlled trial, bacterial eradication rates were 100% for both azithromycin and erythromycin, but gastrointestinal adverse events were reported less frequently with azithromycin (18.8%) compared to erythromycin (41.2%) 4. Additionally, compliance was markedly better with azithromycin (90% took all prescribed doses) compared to erythromycin (only 55% took all prescribed doses) 4.

Special Considerations

Neonates and Young Infants

  • Azithromycin is strongly preferred for infants <1 month due to the risk of IHPS with erythromycin 2, 1
  • The high case-fatality ratio of pertussis in neonates underscores the importance of prompt treatment 2

Timing of Treatment

  • Antibiotics are most effective when started during the early catarrhal stage of illness 5
  • While antibiotics may not affect the course of established paroxysmal cough, they remain important for reducing transmission 5, 4

Drug Interactions and Contraindications

  • Azithromycin should be prescribed with caution to patients with impaired hepatic function 2, 1
  • Avoid concurrent administration of azithromycin with aluminum- or magnesium-containing antacids 2, 1
  • Monitor patients when azithromycin is used with drugs metabolized by cytochrome P450 or those with pharmacokinetic interactions (e.g., digoxin, triazolam, ergot alkaloids) 1
  • Macrolides are contraindicated in patients with history of hypersensitivity to any macrolide agent 2

Additional Management Considerations

  • Patients should be isolated at home and away from work or school for 5 days after starting antibiotic therapy 1
  • Supportive care is important, especially for infants and young children who are at higher risk for complications such as apnea, pneumonia, seizures, or death 5
  • Antibiotics should not be used prophylactically at late periods of pertussis for prevention of secondary bacterial complications, as this may increase risk of complications 6

Common Pitfalls to Avoid

  1. Delaying treatment: Early treatment is crucial for reducing transmission and may help reduce symptom severity if initiated during the catarrhal phase 5

  2. Using erythromycin in neonates: Avoid erythromycin in infants <1 month due to risk of IHPS; use azithromycin instead 2, 1

  3. Poor monitoring of compliance: The 14-day course of erythromycin leads to poor compliance; the shorter 5-day course of azithromycin improves adherence 4

  4. Failure to identify and treat close contacts: Postexposure prophylaxis should be considered for household contacts and those at high risk 1

  5. Overlooking supportive care: While antibiotics address the infection, supportive care is essential, particularly for managing cough paroxysms and preventing complications in young children 5

References

Guideline

Treatment and Prevention of Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pertussis: a reemerging infection.

American family physician, 2013

Research

[Antibiotic therapy in children with pertussis].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.